Akebia Therapeutics, Inc. Common Stock AKBA
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-13T18:10:33.484Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T18:10:21.649816244Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T18:10:32.210488+00:00
Akebia Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 1.39 | 229.3% | 201.9% | |||
| 35Δ | 1.23 | 213.1% | 171.0% | |||
| 40Δ | 1.08 | 197.0% | 140.2% | |||
| 45Δ | 0.92 | 180.8% | 109.4% | 0.55 | 142.9% | 19.6% |
| 50Δ | 0.77 | 164.6% | 78.6% | 0.60 | 140.3% | 17.5% |
| 55Δ | 0.61 | 148.5% | 47.7% | 0.65 | 137.7% | 15.3% |
| 60Δ | 0.70 | 135.1% | 13.1% | |||
| 65Δ | 0.75 | 132.5% | 10.9% | |||
| 70Δ | 0.81 | 129.9% | 8.8% | |||
| 75Δ | 0.86 | 127.3% | 6.6% | |||
| 80Δ | 0.91 | 124.7% | 4.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 1.39
- IV
- 229.3%
- B/E move
- 201.9%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 1.23
- IV
- 213.1%
- B/E move
- 171.0%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 1.08
- IV
- 197.0%
- B/E move
- 140.2%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 0.92
- IV
- 180.8%
- B/E move
- 109.4%
- Pseudo strike
- 0.55
- IV
- 142.9%
- B/E move
- 19.6%
50Δ
- Pseudo strike
- 0.77
- IV
- 164.6%
- B/E move
- 78.6%
- Pseudo strike
- 0.60
- IV
- 140.3%
- B/E move
- 17.5%
55Δ
- Pseudo strike
- 0.61
- IV
- 148.5%
- B/E move
- 47.7%
- Pseudo strike
- 0.65
- IV
- 137.7%
- B/E move
- 15.3%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.70
- IV
- 135.1%
- B/E move
- 13.1%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.75
- IV
- 132.5%
- B/E move
- 10.9%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.81
- IV
- 129.9%
- B/E move
- 8.8%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.86
- IV
- 127.3%
- B/E move
- 6.6%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.91
- IV
- 124.7%
- B/E move
- 4.4%
Options history
Table
| Date | IV (%) |
|---|---|
| 220.33% | |
| 182.58% | |
| 177.59% | |
| 184.48% | |
| 200.06% | |
| 240.47% | |
| 137.77% | |
| 226.26% | |
| 221.94% | |
| 259.07% | |
| 233.94% | |
| 251.56% | |
| 270.20% |
Drug Manufacturers - Specialty & Generic
ALKS
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in…
More →AMLX
Amylyx Pharmaceuticals Inc (AMLX) is an innovative biopharmaceutical company at the forefront of developing transformative therapies for neurodegenerative diseases, particularly…
More →AMPH
Description unavailable
More →AMRX
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic…
More →ANIK
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
More →ANIP
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and…
More →